Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anastrozole in Elderly Hypogonadal Men
NCT00136695Phase 2Completed
- Sponsor
- Massachusetts General Hospital
- Start
- Oct 2004
- Primary completion
- Oct 2008
- Modality
- Irreversible Covalent Inhibitors, Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Hypogonadism comparing Anastrozole 1 mg QD with Placebo (2 arms). Primary endpoint: Change in Lean Body Mass at 1 year. Started Oct 2004; status: completed.
02
Drugs
anastrozole
03
Conditions
Hypogonadism
Beyond the preview
Go deeper on NCT00136695.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00136695.